The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 11, 2017

Filed:

Oct. 30, 2013
Applicant:

Centro DE Inmunologia Molecular, Havana, CU;

Inventors:
Assignee:

Centro De Inmunologia Molecular, Habana, Havana, CU;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/495 (2006.01); A61K 39/39 (2006.01); A61K 47/48 (2006.01); A61K 38/18 (2006.01);
U.S. Cl.
CPC ...
C07K 14/495 (2013.01); A61K 38/1841 (2013.01); A61K 39/39 (2013.01); A61K 47/48215 (2013.01); A61K 47/48415 (2013.01);
Abstract

The present invention relates to the field of Biotechnology and more particularly to the mutated polypeptides of TGFβ molecule whose primary sequence has a high homology with the sequence of human TGFβ. These muteins lose their ability to interact with ALK5 but maintain their ability to interact with other receptors that are part of the receptor complex (TβRII and TβRIII). They have the property of antagonizing the signaling of all natural variants of TGFβ ligands, dependent of ALK5 recruitment in the receptor complex, and have significant immunomodulatory effects. The present invention relates to pharmaceutical compositions comprising as active principle the polypeptides or fusion proteins disclosed and their use thereof given their modulating effect on the immune system in diseases such as cancer, diseases accompanied by fibrosis and chronic infectious diseases.


Find Patent Forward Citations

Loading…